Celebrating its 25th year, Slone Partners is a premier executive search and talent advisory firm delivering visionary leaders and fractional talent who build and scale amazing life sciences and healthcare organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals. To learn more about Slone Partners’ value proposition and our many success stories, visit https://www.slonepartners.com or call 888.784.3422.
Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Over the past few months, numerous healthcare organizations have turned to executive search firms to find new chief medical officers. And in the era of COVID-19 we can expect this to be another burgeoning area for executive search firms. Recently, life sciences-focused search firm Slone Partners placed Mike Spigarelli as chief medical officer of Lumen Bioscience in Seattle,
Life sciences-focused search firm Slone Partners has added esteemed educator Candace Nortey as executive director of diversity, equity and inclusion. In this newly created role, she will help expand the firm’s diversity efforts to enhance opportunities for minority candidates, both internally and for the company’s client partners. “Candace Nortey is an extremely accomplished leader in her field and brings
Sumitovant Biopharma executive Mary Stutts has joined the advisory board of executive search firm Slone Partners. Ms. Stutts is a renowned C-level global branding and growth expert who has provided strategic counsel in the biotechnology, healthcare, technology, and media industries at Fortune 200 companies including Genentech, Bayer, Bristol Myers Squibb, Kaiser Permanente, UnitedHealth Group, and Comcast
Executive search firm Slone Partners has recruited Ingo Chakravarty as the new president and CEO of Mesa Biotech. He assumes leadership of the company less than two months after it received emergency use authorization from the Federal Drug Administration to market its 30-minute point-of-care molecular SARS-CoV-2 test. Mr. Chakravarty succeeds Dr. Hong Cai, co-founder and CEO of Mesa Biotech since
(Dec. 3, 2020) Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of John Leite as Chief Business Officer at InterVenn Biosciences. In his new role, Leite will direct all business operations for the company as part of its global leadership team. Over the past six
I might be a bit biased, but I’ve always thought Slone Partners is an amazing place to work. So, it was particularly gratifying to learn that the Washington Post agrees when it named our firm among the nation’s Top Workplaces 2021. I’m elated to share this honor with such eminent companies and non-profits as AARP, Capital One, Carfax,
SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of Nipun Soni, CFA, CPA, as the Chief Financial Officer (CFO) at BillionToOne, Inc., the precision diagnostics company. Soni is a seasoned and respected finance executive with more than 20 years of broad financial experience spanning across high-growth
SOUTH RIDING, VA. – A year after the tragic death of George Floyd sparked a renewed push for greater racial and social justice in this country, Slone Partners CEO Leslie Loveless and Candace Nortey, the company’s Executive Director of Diversity, Equity, and Inclusion (DEI), are citing “signs of progress” in the effort to achieve DEI in the life sciences.
New board members bring more than 45 years of combined pharmaceutical industry experience SOUTH RIDING, VA. – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and diagnostics companies, has announced the placements of Stacy R. Lindborg and Christine Pellizzari on the Board of Directors at Celsion Corporation, a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines. Dr. Lindborg